Sam Milstein
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
-
- Supramolecular Self-Assembly in Materials
- Nanoparticle-Based Drug Delivery
Papers in
-
- Protein purification and stability 7
- Chemical Synthesis and Analysis 5
- Lipid Membrane Structure and Behavior 3
- Microbial Metabolic Engineering and Bioproduction 2
-
- Advanced Drug Delivery Systems 4
- Co-authors
- Joseph B. Guttenplan (2 shared papers)H Leipold (4 shared papers)Marina R. Kasimova (2 shared papers)Ernesto Freire (2 shared papers)Donald Sarubbi (5 shared papers)Andrea Leone‐Bay (4 shared papers)Otto Phanstiel (3 shared papers)David A. Edwards (2 shared papers)
- Journals
- Journal of Controlled Release (3 papers)Journal of the American Chemical Society (2 papers)Journal of Bioactive and Compatible Polymers (2 papers)Pharmaceutical Research (1 paper)Carcinogenesis (1 paper)
- Partner nations
- United StatesRussiaCanada
In The Last Decade
Sam Milstein
19 papers receiving 404 citations
Peers
Comparison fields: 5 of 83
- Pharmaceutical Science 136
- Biomaterials 81
- Molecular Biology 229
- Molecular Medicine 13
- Internal Medicine 9
Countries citing papers authored by Sam Milstein
This map shows the geographic impact of Sam Milstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Milstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Milstein more than expected).
Fields of papers citing papers by Sam Milstein
This network shows the impact of papers produced by Sam Milstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Milstein. The network helps show where Sam Milstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Sam Milstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 61 | |
| 2 | 1998 | 50 | |
| 3 | 1993 | 48 | |
| 4 | 1994 | 42 | |
| 5 | 1982 | 31 | |
| 6 | 1994 | 29 | |
| 7 | 2000 | 29 | |
| 8 | 1998 | 28 | |
| 9 | 2000 | 24 | |
| 10 | 1998 | 23 | |
| 11 | 1995 | 23 | |
| 12 | 1979 | 20 | |
| 13 | 1996 | 16 | |
| 14 | 1996 | 7 | |
| 15 | 1997 | 7 | |
| 16 | 1996 | 7 | |
| 17 | 1996 | 3 | |
| 18 | 1996 | 1 | |
| 19 | 1994 | 1 |
About Sam Milstein
Sam Milstein is a scholar working on Molecular Biology, Pharmaceutical Science, Organic Chemistry, Endocrinology, Diabetes and Metabolism and Materials Chemistry, having authored 19 papers that have together received 450 indexed citations. Recurring topics across this work include Protein purification and stability (7 papers), Chemical Synthesis and Analysis (5 papers), Advanced Drug Delivery Systems (4 papers), Lipid Membrane Structure and Behavior (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Analytical Chemistry and Chromatography (2 papers), Supramolecular Self-Assembly in Materials (2 papers) and Microbial Metabolic Engineering and Bioproduction (2 papers). The work is most often cited by research in Pharmaceutical Science (136 citations), Biomaterials (81 citations), Molecular Biology (229 citations), Molecular Medicine (13 citations) and Internal Medicine (9 citations). Sam Milstein has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Joseph B. Guttenplan, H Leipold, Marina R. Kasimova, Ernesto Freire, Donald Sarubbi, Andrea Leone‐Bay, Otto Phanstiel, David A. Edwards, Brian R. Stoll and Raymond J. Bergeron. Their work appears in journals such as Journal of Controlled Release, Journal of the American Chemical Society, Journal of Bioactive and Compatible Polymers, Pharmaceutical Research and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.